ADAG

NASD Adagene, Inc. Sponsored ADR
Oct 4, 2026 · 3:16 PM ET EOD Market Closed

$2.85 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.85, $0.15 below the day’s high of $3.00

YTD change
+50.79%
vs 20-day SMA
-11.89%
vs 200-day SMA
-14.72%

Price ranges

Previous day
$2.80 $3.00
open $2.96 close $2.85
-$0.11 (-3.72%)
Today
$2.80 $3.00
$2.85
Past week
$2.87 $3.47
from $2.98 now $2.85
-$0.13 (-4.36%)
Past month
$2.81 $3.85
from $3.69 now $2.85
-$0.84 (-22.76%)
This year
$1.50 $4.85
from $1.89 now $2.85
+$0.96 (+50.79%)

Price & Performance

-1.47 (-34.03%) / 6M

$2.70$3.44$4.19$4.93Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 91.0% away from all-time highs of $31.83
  • ADAG is up 51% since the beginning of the year
  • ADAG is up 47% over the past 12 months
  • ADAG is down 23% over the past 1 month
  • 3% of all ADAG investors are betting against ADAG

ADAG reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +43.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.26
Earnings momentum +7.1% Quarterly EPS growth
Quarterly change +7.1%

Valuation

P/E ratio N/A
Enterprise value $60.6M
Beta 0.52

Balance sheet & scale

IncomeN/A
Revenue$9.3M
Cash$127.9M
Debt$6.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $239.2M

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $403.04 -1.04%
MRNA Moderna, Inc. $190.01 +0.57%
RVMD Revolution Medicines, Inc. $206.64 +0.36%
ROIV Roivant Sciences Ltd. $35.72 +0.62%
BNTX BioNTech SE Sponsored ADR $96.90 +0.05%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.